logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5145.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5145.produseast1
Journal Article
|Research

Availability and affordability of treatment for Human African Trypanosomiasis

Etchegorry MG, Helenport J, Pecoul B, Jannin J, Legros D
Download

Similar Content
Loading...
Loading...
Loading...
Abstract
Human African Trypanosomiasis (HAT) is a re-emerging disease whose usual treatments are becoming less efficient because of the increasing parasite resistance. Availability of HAT drugs is poor and their production in danger because of technical, ecological and economic constraints. In view of this dramatic situation, a network involving experts from NGOs, WHO and pharmaceutical producers was commissioned with updating estimates of need for each HAT drug for the coming years; negotiations with potential producers of new drugs such as eflornithine; securing sustainable manufacturing of existing drugs; clinical research into new combinations of these drugs for first and second-line treatments; centralizing drug purchases and their distribution through a unique non-profit entity; and addressing regulatory and legal issues concerning new drugs.

Languages

English
DOI
10.1046/j.1365-3156.2001.00764.x
Published Date
01 Nov 2001
PubMed ID
11703853
Journal
Tropical Medicine and International Health
Volume | Issue | Pages
Volume 6, Issue 11, Pages 957-959
Dimensions Badge
Availability and affordability of treatment for Human African Trypanosomiasis | Journal Article / Research | MSF Science Portal